Financial assistance is available through the Rasuvo® (methotrexate) injection patient support program.
Learn about the various financial resources for your patients below.
The Co-pay Assistance Program will provide financial support of up to $125 per month for 12 months. Your patients may have a $0 co-pay depending on their coverage.
For reimbursement services and patient eligibility determinations, call the Rasuvo Benefits Support Line, from 8:00 AM-8:00 PM ET Monday-Friday (excluding holidays).
Medac Pharma, Inc. is committed to helping patients afford their Rasuvo® (methotrexate) injection medication. Eligible patients will have an enrollment duration of 1 year, after which they may apply again. To learn more, call our Benefits Support Helpline. Other terms and conditions may apply.
Patient Referral Benefit Support Form
This form is used to assist with Benefit Investigations and Personalized Pharmacy Support. For questions, please call the Rasuvo Benefits Support Line, from 8:00 AM-8:00 PM ET Monday-Friday (excluding holidays). Fax completed forms to 800-481-3325.
References: 1. Managed Market Insight & Technology, LLC, database as of October 2016. 2. Data on file. Medac Pharma, Inc.
Rasuvo is indicated for the:
Common adverse reactions are: nausea, abdominal pain, dyspepsia, stomatitis/mouth sores, rash, nasopharyngitis, diarrhea, liver function test abnormalities, vomiting, headache, bronchitis, thrombocytopenia, alopecia, leukopenia, pancytopenia, dizziness, photosensitivity, and "burning of skin lesions". The most frequently reported adverse reactions include ulcerative stomatitis, leukopenia, nausea, and abdominal distress. Other frequently reported adverse reactions are malaise, undue fatigue, chills and fever, dizziness and decreased resistance to infection.
Rasuvo is for once weekly subcutaneous use only.
Administer Rasuvo in the abdomen or thigh.